Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 62.53% is in line with its 5-year average of 59.61%, around the middle of its 5-year range (43.72%–81.50%).
2.19% below its 12-month average of 63.93%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 62.00%.
GROSS MARGIN
62.53%
GROSS MARGIN AVG TTM
63.93%
GROSS MARGIN AVG 3Y
63.49%
GROSS MARGIN AVG 5Y
59.61%
GROSS MARGIN AVG 10Y
61.50%
GROSS MARGIN AVG 15Y
43.91%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.19%
CURRENT VS 3Y AVG
-1.51%
CURRENT VS 5Y AVG
+4.90%
CURRENT VS 10Y AVG
+1.67%
CURRENT VS 15Y AVG
+42.39%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
+49.74%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$137.77M
Gross Margin
62.53%
TTM Avg
63.93%
3Y Avg
63.49%
5Y Avg
59.61%
Market Cap
$136.65M
Gross Margin
61.99%
TTM Avg
62.83%
3Y Avg
59.84%
5Y Avg
59.96%
Market Cap
$139.33M
Gross Margin
57.63%
TTM Avg
59.89%
3Y Avg
61.87%
5Y Avg
62.78%
Market Cap
$139.47M
Gross Margin
81.26%
TTM Avg
40.63%
3Y Avg
20.32%
5Y Avg
13.54%
Market Cap
$143.39M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
12.53%
5Y Avg
23.21%
Market Cap
$144.02M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
-394.61%
5Y Avg
-639.25%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $137.77M | 62.53% | 63.93% | 63.49% | 59.61% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | 61.99% | 62.83% | 59.84% | 59.96% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $139.33M | 57.63% | 59.89% | 61.87% | 62.78% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | 81.26% | 40.63% | 20.32% | 13.54% |
| LifeMD, Inc. (LFMD)vs › | $135.17M | 85.91% | 84.21% | 85.09% | 82.87% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 63.13% | 64.40% | 63.36% | 62.40% |
| Freenome, Inc. (FRNM)vs › | $132.66M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $143.39M | 0.00% | 0.00% | 12.53% | 23.21% |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.02M | 100.00% | 100.00% | -394.61% | -639.25% |
| Organigram Global Inc. (OGI)vs › | $131.22M | 3.67% | 16.70% | 18.97% | 8.54% |
Gross Margin
62.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 62.00% |
| 2026-03-31 | 54.21% |
| 2025-12-31 | 66.17% |
| 2025-09-30 | 67.36% |
| 2025-06-30 | 69.91% |
| 2025-03-31 | 63.54% |
| 2024-12-31 | 61.61% |
| 2024-09-30 | 63.87% |
| 2024-06-30 | 56.09% |
| 2024-03-31 | 53.94% |
| 2023-12-31 | 69.84% |
| 2023-09-30 | 81.50% |
| 2023-06-30 | 55.33% |
| 2023-03-31 | 48.11% |
| 2022-12-31 | 47.93% |
| 2022-09-30 | 56.31% |
| 2022-06-30 | 59.58% |
| 2022-03-31 | 65.71% |
| 2021-12-31 | 43.72% |
| 2021-09-30 | 47.04% |
| 2021-06-30 | 58.06% |
| 2021-03-31 | 66.27% |
| 2020-12-31 | 64.47% |
| 2020-09-30 | 64.34% |
| 2020-06-30 | 66.97% |
| 2020-03-31 | 70.51% |
| 2019-12-31 | 68.01% |
| 2019-09-30 | 72.35% |
| 2019-06-30 | 74.21% |
| 2019-03-31 | 70.91% |
| 2018-12-31 | 101.01% |
| 2018-09-30 | 20.81% |
| 2018-06-30 | 19.18% |
| 2018-03-31 | 17.41% |
| 2017-12-31 | 14.98% |
| 2017-09-30 | 12.68% |
| 2017-06-30 | 14.67% |
| 2017-03-31 | 13.90% |
| 2016-12-31 | 12.93% |
| 2016-09-30 | 95.79% |
| 2016-06-30 | 85.47% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
